...
机译:非限制性心脏合并症患者的曲妥珠猴与相关的心脏毒性
Medical OncologyCardinal Massaia HospitalAsti Italy;
Multidisciplinary Oncology Outpatient Clinic Candiolo Cancer Institute FPO-IRCCSTurin Italy;
Medical Oncology BRegina Elena National Cancer InstituteRome Italy;
Medical Oncology 2AOU Citta' della Salute e della ScienzaTurin Italy;
Medical OncologyIRCCS AOU San Martino ‐ ISTGenova Italy;
Medical OncologyS. Croce e Carle Teaching HospitalCuneo Italy;
Medical OncologyS. Lorenzo HospitalCarmagnola Turin Italy;
Medical Oncology BRegina Elena National Cancer InstituteRome Italy;
Medical OncologyIRCCS AOU San Martino ‐ ISTGenova Italy;
Medical Oncology 2AOU Citta' della Salute e della ScienzaTurin Italy;
Multidisciplinary Oncology Outpatient Clinic Candiolo Cancer Institute FPO-IRCCSTurin Italy;
CardiologyCandiolo Cancer Institute FPO‐ IRCCSTurin Italy;
Multidisciplinary Oncology Outpatient Clinic Candiolo Cancer Institute FPO-IRCCSTurin Italy;
breast cancer; cardiac comorbidity; cardiotoxicity; trastuzumab;
机译:非限制性心脏合并症患者的曲妥珠猴与相关的心脏毒性
机译:曲妥珠单抗相关的心脏毒性和HER2阳性转移性乳腺癌患者的心脏护理
机译:心脏生物标志物,用于早期检测和预测HERS2阳性早期乳腺癌患者的曲妥珠单抗和/或拉帕替尼诱导的心脏毒性:Neoaltto Sub-China(大1-06)
机译:COPD患者中的心脏病性通过HRV和呼吸指数解释
机译:开发一种突出的人瑞尼尼心毒性模型,以评估机械载荷使用工程心脏的作用
机译:无心脏危险因素的患者长期不可逆转的曲妥珠单抗对转移性乳腺癌的心脏毒性
机译:年轻的调查员奖课程 - 临床科学4422LEFT束枝块和冠状动脉疾病在冠状动脉CT血管造影443焦心肌纤维化和异常左心室患者患者患者心脏病的临床证据44464ARHGAP24,是FIBRO弹性缺乏二尖瓣脱垂的第一个基因一种使用ASE / EACVI标准检测蒽曲霉和曲妥珠菇治疗乳腺癌患者亚临床心脏毒性的表型研究445